Zacks Investment Research downgraded shares of athenahealth from a buy rating to a hold rating, according to MarketBeat, which cites a research note published April 22.
Here are four quick facts.
1. Zacks said athenahealth's fourth-quarter 2015 earnings were impressive, driven by healthy growth across athenahealth-branded services as well as physician additions at all three software suites, according to Mas Market News. "We believe that athenahealth's strong product portfolio, expanding physician base and unique business model will continue to drive the top line," Zacks added.
2. However, athenahealth has challenges, including lack of enterprise-sized deals, winding up of government funded stimulus and increasing competition in the health IT market, Zacks said, according to Mas Market News.
3. Shares of athenahealth opened at $138.64 Monday.
4. athenahealth has a 12-month low of $110.68 and a 12-month high of $170.42.
More articles on finance and revenue cycle management:
Elliot Hospital's pediatric ICU to close: 3 things to know
Arkansas governor provides lifeline for state's hybrid Medicaid expansion
News outlets launch reporting project to bring clarity to healthcare costs in Florida